Skip to main content
. Author manuscript; available in PMC: 2010 Mar 9.
Published in final edited form as: Hum Mol Genet. 2008 Jan 4;17(8):1063–1075. doi: 10.1093/hmg/ddm379

Table 1.

Protein expression and survival data for PrP-SMN and HSA-SMN transgenic SMA animals

Line Copy no. Protein expression Mean lifespan in days
Brain Spinal cord Heart Muscle Liver Heterozygous Homozygous
PrP-SMN
 92 8–9 +++ +++ − + + 150 ± 100 (n = 21) 210 ± 97 (n = 46)
 13 1 − − − − − 7.0 ± 0.7 (n = 36) Maximum 28
HSA-SMN
 63 5 + + +++ +++ + 6.6 ± 0.8 (n = 29) 160 ± 33.9 (n = 20)
 69 11 − − − +++ − ND 3.5 ± 0.5 (n = 15)
Controls
 SMA + − − − − 4.6 ± 0.4 (n = 33)
 Carrier ++ ++ + + + Normal (21)
 High copy +++ +++ ++ ++ ++ Normal (21)

For protein expression data PrP92, PrP13, HSA63, HSA69, animals are all homozygous for the HSA-SMN or PrP-SMN transgene, SMN2 and do not contain mouse Smn. Protein expression determined by western blot analysis on tissue from PND05 animals.

Copy no. refers to the number of copies of the PrP or HSA transgenes.

‘−’ not detectable, ‘+’ low, ‘++’ medium, ‘+++’ high expression, ND = not determined, n = number of mice.

For mean lifespan in days heterozygous and homozygous refer to the transgene, all animals are homozygous for SMN2 and do not contain mouse Smn.